At the core of Nyxoah and everything we do is about people first.

All of us at Nyxoah hope that you and your loved ones are safe in the current COVID-19 pandemic.

In these unprecedented times, the safety and health of our employees and our patients as well as the physicians and medical staff who treat them are of the utmost importance.

We have moved quickly to protect our people and our patients, following public health guidelines for social distancing and isolation in all of our international markets, whilst continuing to support them virtually. We keep monitoring the evolving COVID-19 situation very closely and are ready to adjust our activities accordingly.

OSA disrupts the lives of millions of people worldwide and Nyxoah remains committed to support patients and their physicians in their quest for restful nights. As a Nyxoah patient, we encourage you to contact your local physician and clinic if you have questions regarding your scheduled care.

The team at Nyxoah remains available to answer any open question through our contact form or via e-mail

May you stay safe and healthy,

Olivier Taelman
Chief Executive Officer, Nyxoah

Visit the FAQ

Frequently asked questions
about the Genio® system


All rights reserved © 2021 Nyxoah SA. All content on this presentation, including the texts, trademarks, service marks, logos, illustrations, photos, graphics, design etc., are the property of Nyxoah SA. Nyxoah SA. owns all rights with respect to any of their trademarks, service marks, logos, and copyrighted works appearing on this presentation. Patented and design protected technology. Device not for sale in U.S. The Genio® system by Nyxoah is intended to be used for patients who suffer from moderate to severe Obstructive Sleep Apnea (AHI of 15 to 65), have not tolerated, failed or refused PAP therapy and are not significantly overweight. Reviewed and approved: February 2020